Head-to-Head

ABBVIE INC. vs. Nektar Therapeutics

ABBV

ABBVIE INC.

$286.20 +0.94%

VS NKTR

Nektar Therapeutics

$30.20 -7.19%

ABBVIE INC. (ABBV) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABBVNKTR
Market Cap $505.89 billion $1.11 billion

ABBV leads on 1 of 1 size & scale factors.

Dividend

ABBVNKTR
Dividend Yield 2.54% —

ABBV and NKTR split the dividend factors evenly.

Risk & Sentiment

ABBVNKTR
Short Interest 0.85% 31.24%

ABBV leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABBV overview, ABBV financials, NKTR overview, NKTR financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.